Myriad Genetics, Inc. has launched a new educational website called "Know More Sooner," aimed at providing detailed information about reproductive and prenatal genetic testing. The site seeks to ...

During pregnancy, there are a variety of tests performed to keep track of the health of both the mother and the unborn child. Prenatal genetic testing is optional but gives parents-to-be information ...

Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...

A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...

While noninvasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by allowing the detection of a number of genetic problems in a fetus, it is currently limited and thus misses many ...

While non-invasive prenatal testing (NIPT) has revolutionised prenatal diagnostics by allowing the detection of a number of ...

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY ® non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD ...

Prenatal detection of arthrogryposis multiplex congenita (AMC) remains an ongoing challenge. AMC is a rare congenital condition characterized by multiple contractures affecting various joints [1].

Researchers have developed a non-invasive genetic test that can screen the blood of pregnant individuals to survey all genes from the fetal genome. A team of investigators from Massachusetts General ...